MENU
+Compare
JAZZ
Stock ticker: NASDAQ
AS OF
Aug 11, 04:59 PM (EDT)
Price
$110.83
Change
-$0.47 (-0.42%)
Capitalization
6.75B

JAZZ Jazz Pharmaceuticals plc Forecast, Technical & Fundamental Analysis

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology... Show more

JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for JAZZ with price predictions
Aug 08, 2025

JAZZ in upward trend: price rose above 50-day moving average on August 07, 2025

JAZZ moved above its 50-day moving average on August 07, 2025 date and that indicates a change from a downward trend to an upward trend. In of 60 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where JAZZ's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where JAZZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for JAZZ crossed bullishly above the 50-day moving average on July 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JAZZ advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

JAZZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 197 cases where JAZZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on JAZZ as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for JAZZ turned negative on August 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JAZZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JAZZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.821) is normal, around the industry mean (18.662). P/E Ratio (15.380) is within average values for comparable stocks, (54.033). JAZZ's Projected Growth (PEG Ratio) (9.184) is very high in comparison to the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (1.681) is also within normal values, averaging (286.048).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JAZZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

View a ticker or compare two or three
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

JAZZ is expected to report earnings to fall 164.00% to $5.28 per share on November 05

Jazz Pharmaceuticals plc JAZZ Stock Earnings Reports
Q3'25
Est.
$5.28
Q2'25
Missed
by $0.63
Q1'25
Missed
by $3.13
Q4'24
Beat
by $0.81
Q3'24
Beat
by $1.11
The last earnings report on August 05 showed earnings per share of -825 cents, missing the estimate of -761 cents. With 216.65K shares outstanding, the current market capitalization sits at 6.75B.
A.I. Advisor
published General Information

General Information

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Waterloo Road
Phone
+353 16347800
Employees
2800
Web
https://www.jazzpharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFSSX16.010.07
+0.44%
Hartford Schroders Intl Cntrrn Val SDR
USDCHF0.810.00
+0.15%
United States Dollar - Switzerland Franc
SGQIX44.670.02
+0.04%
DWS International Growth Inst
REEAX15.13-0.05
-0.33%
RBC Emerging Markets Equity A
WBIGX29.48-0.16
-0.54%
William Blair International Growth N

JAZZ and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with TECH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
-0.70%
TECH - JAZZ
40%
Loosely correlated
+0.54%
FTRE - JAZZ
39%
Loosely correlated
-9.12%
DAWN - JAZZ
37%
Loosely correlated
+1.16%
ROIV - JAZZ
37%
Loosely correlated
-0.52%
SYRE - JAZZ
36%
Loosely correlated
N/A
More